PubRank

H Kuzuya

Author PubWeight™ 64.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 1986 3.09
2 Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977 2.79
3 Characterization of seven C-peptide antisera. Diabetes 1978 2.29
4 Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A 1985 2.03
5 A simple and sensitive assay for dopamine-beta-hydroxylase activity by dual-wavelength spectrophotometry. Biochem Med 1974 1.72
6 Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Science 1988 1.61
7 The effect of fibroblast growth factor on PC12 cells. J Neurosci 1985 1.58
8 Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 1978 1.42
9 A candidate case for lymphocytic infundibulo-neurohypophysitis mimicking a neurohypophysial tumor. Intern Med 1997 1.38
10 Calcium-activated, phospholipid-dependent protein kinase in rat pancreas islets of langerhans. Its possible role in glucose-induced insulin release. FEBS Lett 1982 1.25
11 C-peptide suppression test for insulinoma. J Lab Clin Med 1977 1.21
12 Heterogeneity of circulating C-peptide. J Clin Endocrinol Metab 1977 1.01
13 Circulating serum C-peptide. A brief review of diagnostic implications. N Engl J Med 1976 0.97
14 14-3-3beta protein associates with insulin receptor substrate 1 and decreases insulin-stimulated phosphatidylinositol 3'-kinase activity in 3T3L1 adipocytes. J Biol Chem 1998 0.97
15 Change of insulin action with aging in conscious rats determined by euglycemic clamp. Am J Physiol 1988 0.96
16 Inhibition of dopamine beta-hydroxylase by sulfhydryl compounds and the nature of the natural inhibitors. Biochim Biophys Acta 1967 0.94
17 Clinical significance of circulating proinsulin and C-peptide. Recent Prog Horm Res 1976 0.93
18 Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy. Am J Med 1975 0.92
19 Effects of ML-9 on insulin stimulation of glucose transport in 3T3-L1 adipocytes. J Biol Chem 1993 0.91
20 Abnormalities in circulating beta cell peptides in chronic renal failure: comparison of C-peptide, proinsulin and insulin. J Clin Endocrinol Metab 1977 0.89
21 Carbohydrate metabolism in pregnancy. XV. Plasma C-peptide during intravenous glucose tolerance in neonates from normal and insulin-treated diabetic mothers. J Clin Endocrinol Metab 1978 0.88
22 Circadian variation of serum glucose, C-peptide immunoreactivity and free insulin normal and insulin-treated diabetic pregnant subjects. Diabetologia 1976 0.86
23 Reduced expression of the leptin gene (ob) by catecholamine through a G(S) protein-coupled pathway in 3T3-L1 adipocytes. Diabetes 1996 0.86
24 Heterogeneity of circulating human C-peptide. Diabetes 1978 0.85
25 Clinical, endocrine and metabolic aspects of the Werner syndrome compared with those of normal aging. Adv Exp Med Biol 1985 0.85
26 Somatostatin-like immunoreactivity in human peripheral plasma measured by radioimmunoassay following affinity chromatography. Diabetes 1981 0.84
27 Long-term, heterologous down-regulation of the epidermal growth factor receptor in PC12 cells by nerve growth factor. J Cell Biol 1987 0.82
28 Regulation of glucose-transporter gene expression by insulin in cultured human fibroblasts. Diabetes 1988 0.81
29 Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptin. Am J Physiol Endocrinol Metab 2001 0.81
30 Cerulein-induced pancreatic polypeptide secretion. Its inhibition by atropine and its possible role in regulating gallbladder relaxation. Am J Gastroenterol 1980 0.81
31 Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes 1997 0.80
32 A 35 kDa mannose-binding lectin with hemagglutinating and mitogenic activities from "Kidachi Aloe" (Aloe arborescens Miller var. natalensis Berger). J Biochem 1995 0.79
33 A simple assay of dopamine beta-hydroxylase activity in the homogenate of the adrenal medulla. Enzymologia 1969 0.79
34 Postreceptor defect in insulin action in streptozotocin-induced diabetic rats. Am J Physiol 1989 0.79
35 Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation. Biochem J 1993 0.79
36 Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD). Clin Exp Immunol 1998 0.79
37 The phytochemical lindleyin, isolated from Rhei rhizoma, mediates hormonal effects through estrogen receptors. J Endocrinol 2002 0.79
38 Effect of starvation on somatostatin content of pancreas and gastrointestinal tract of the guinea pig. Horm Metab Res 1982 0.78
39 Dopamine beta-hydroxylase and tyrosine hydroxylase activities in spontaneously hypertensive rats after NaCl administration. Experientia 1975 0.78
40 Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders. Arch Intern Med 1977 0.78
41 Starvation-induced changes of somatostatin, glucagon, and insulin secretion from the isolated perfused rat pancreas. Diabetes 1980 0.78
42 Restriction fragment length polymorphism (RFLP) of the human insulin receptor gene in Japanese: its possible usefulness as a genetic marker. Diabetologia 1986 0.78
43 The complete amino acid sequence of a mannose-binding lectin from "Kidachi Aloe" (Aloe arborescens Miller var. natalensis Berger). Biochem Biophys Res Commun 1995 0.78
44 Regulation of nerve growth factor action on Nsp100 phosphorylation in PC12h cells by calcium. J Neurochem 1986 0.78
45 Inhibition of dopamine beta-hydroxylase by fusaric acid (5-butylpicolinic acid) in vitro and in vivo. Biochem Pharmacol 1970 0.78
46 Inhibition of azoxymethane-induced aberrant crypt foci formation in rat colorectum by whole leaf Aloe arborescens Miller var. natalensis Berger. Phytother Res 2001 0.78
47 Dopamine-beta-hydroxylase activity in serum of developing rats. Experientia 1976 0.78
48 Effects of thyroid hormone on catecholamine and its metabolite concentrations in rat cardiac muscle and cerebral cortex. Thyroid 1998 0.78
49 Flavins and monoamine oxidase activity in the brain, liver and kidney of the developing rat. J Neurochem 1969 0.77
50 Increased affinity of insulin receptor on hepatocytes from streptozotocin-induced diabetic rats. Endocrinol Jpn 1984 0.77
51 Immunogenetics of early-onset insulin-dependent diabetes mellitus among the Japanese: HLA, Gm, BF, GLO, and organ-specific autoantibodies--the J.D.S. study. Diabetes Res Clin Pract 1990 0.77
52 Wheat germ agglutinin inhibits the effects of nerve growth factor on the phosphorylation of proteins in PC12h cells. J Neurochem 1985 0.77
53 Purification and characterization of a trypsin-like protease in the submandibular gland of rats. J Biochem 1986 0.77
54 Preparation of anti-phosphoserine and anti-phosphothreonine antibodies and their application in the study of insulin- and EGF-induced phosphorylation. Biochem Biophys Res Commun 1993 0.77
55 Inhibition of dopamine-beta-hydroxylase by spinochrome A and echinochrome A, naphthoquinone pigments of echinoids. Biochem Pharmacol 1973 0.77
56 Effect of truncal vagotomy on pancreatic polypeptide response after intravenous glucose administration. Regul Pept 1981 0.77
57 Changes of X-prolyl dipeptidyl-aminopeptidase activity in developing rat brain. Experientia 1979 0.76
58 ICA and organ-specific autoantibodies among Japanese patients with early-onset insulin-dependent diabetes mellitus--the JDS study. Diabetes Res Clin Pract 1994 0.76
59 Binding activity and autophosphorylation of the insulin receptor from patients with myotonic dystrophy. J Lab Clin Med 1990 0.76
60 Insulin binding to erythrocytes in diabetic patients. Endocrinol Jpn 1981 0.76
61 Hyperfunction of the entero-PP axis in non-insulin dependent diabetes mellitus. Horm Metab Res 1983 0.76
62 Changes in insulin receptor kinase with aging in rat skeletal muscle and liver. Am J Physiol 1990 0.76
63 A novel substrate for insulin-sensitive serine/threonine kinase in intact cells. Endocrinology 1994 0.76
64 Clinical manifestations due to a point mutation of the mitochondrial tRNAleu(UUR) gene in five families with diabetes mellitus. Intern Med 1998 0.75
65 Defective processing of insulin-receptor precursor in cultured lymphocytes from a patient with extreme insulin resistance. J Clin Invest 1988 0.75
66 Insulin sensitivity and glycemic control before and after parathyroidectomy in a diabetic patient with familial multiple endocrine neoplasia type 1. Endocr J 1994 0.75
67 Monoclonal antibodies possibly recognize conformational changes in the human erythrocyte glucose transporter. Biochem J 1992 0.75
68 Insulin-induced activation of phosphoinositide 3-kinase in Fao cells. Diabetologia 1996 0.75
69 [Determination of higher fatty acids in the normal human enamel and dentine]. Igaku To Seibutsugaku 1967 0.75
70 [C peptide and pro-insulin]. Nihon Rinsho 1977 0.75
71 Partial characterization of monoamine oxidase in the salivary gland of rats. Jpn J Pharmacol 1980 0.75
72 [Cardiovascular effects of the thiazolidinedione troglitazone]. Nihon Rinsho 2000 0.75
73 Ester-like groups in human dentine collagen. Arch Oral Biol 1967 0.75
74 [MHC class II antigen and other genes in NIDDM]. Nihon Rinsho 1991 0.75
75 Insulin-stimulated glucose uptake and fasting blood glucose. Endocrinol Jpn 1991 0.75
76 Mechanisms of increase in amylase activity in rat submandibular and sublingual glands after administration of pilocarpine. Arch Oral Biol 1982 0.75
77 Effects of insulin secretagogues and inhibitors on phospholipid metabolism in Langerhans' islets of rat pancreas. Biochem Biophys Res Commun 1983 0.75
78 Glucose regulation of arginine-induced pancreatic somatostatin release from the isolated perfused rat pancreas. Regul Pept 1982 0.75
79 Effects of antisomatostatin and antiglucagon sera on insulin release from isolated Langerhans' islets of rats. Horm Metab Res 1981 0.75
80 Amylase released from the parotid gland by pilocarpine elevates the enzyme activity in the submandibular and sublingual glands of rats. Experientia 1982 0.75
81 [Developmental changes in catecholamine synthesizing enzymes in periphery (author's transl)]. Tanpakushitsu Kakusan Koso 1981 0.75
82 [Myotonic dystrophy]. Nihon Rinsho 1998 0.75
83 Quantitative changes in amylase activity in the salivary glands, pancreas, saliva, and serum after administration of isoproterenol, pilocarpine, and acetylcholine. J Dent Res 1983 0.75
84 [Secretion of injected vitamin B2 into the saliva]. Igaku To Seibutsugaku 1966 0.75
85 Effect of glucagon antiserum on somatostatin, glucagon and insulin release from the isolated perfused rat pancreas. Peptides 1982 0.75
86 Endogenous inhibitors of DOPA decarboxylase in rat submandibular gland. Arch Oral Biol 1980 0.75
87 A new approach to the detection of autoantibodies against insulin receptors that inhibit the internalization of insulin into human cells. Diabetes 1984 0.75
88 [Diagnosis of anomalies of hormone receptors]. Nihon Rinsho 1979 0.75
89 Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agent. Eur J Pharmacol 1996 0.75
90 Somatostatin, insulin, and glucagon secretion from isolated perfused pancreas of obese rats. Am J Physiol 1981 0.75
91 The effect of ventromedial hypothalamic nuclei destruction on somatostatin and insulin release from the isolated perfused rat pancreas. Life Sci 1981 0.75
92 Anti-phosphoserine and anti-phosphothreonine antibodies modulate autophosphorylation of the insulin receptor but not EGF receptor. Biochem Biophys Res Commun 1993 0.75
93 Abnormal pancreatic polypeptide response to oral glucose loading diabetes mellitus. Clin Endocrinol (Oxf) 1980 0.75
94 Transport to the bloodstream of amylase following retrograde infusion of amylase into the parotid glands in the rat. Arch Oral Biol 1984 0.75
95 Effects of M16209, a new antihyperglycemic agent, on insulin sensitivity in vivo: euglycemic clamp studies in rats. Metabolism 1996 0.75
96 [Levels of thyroid hormones in plasma in patients with anorexia nervosa (author's transl)]. Horumon To Rinsho 1979 0.75
97 Enhancement of the cytocidal effect of mitomycin C by means of simultaneous administration of prostaglandin E1. Gan 1983 0.75
98 Inhibitory effects of aloe carboxypeptidase fraction on streptozotocin-induced enhancement of vascular permeability in the pancreatic islets. Phytomedicine 2005 0.75
99 Effects of streptococcal preparation OK-432 on chemically-induced intestinal carcinoma in rats. Nagoya J Med Sci 1980 0.75
100 [Disturbance of mineral metabolism]. Nihon Rinsho 1997 0.75
101 The phenylalanine-binding protein of Comamonas sp. (ATCC 11299a). J Biol Chem 1971 0.75
102 On the preparation and characterization of standard materials for natural human proinsulin and C-peptide. Diabetes 1978 0.75
103 [Insulin resistant diabetes]. Nihon Rinsho 1971 0.75
104 A highly sensitive enzyme immunoassay of anti-insulin antibodies in human serum. Clin Chim Acta 1987 0.75
105 Monoamine oxidase activities towards biogenic monoamines in several regions of rat brain. J Neurochem 1975 0.75
106 Regulation of glucose transporter synthesis in cultured human skin fibroblasts. Mol Cell Endocrinol 1991 0.75
107 [Glucose intolerance associated with aging: tissue sensitivity to insulin assessed by euglycemic glucose clamp]. Nihon Ronen Igakkai Zasshi 1983 0.75
108 Amino acid composition of insoluble protein from the dentine of human deciduous and permanent teeth. Arch Oral Biol 1971 0.75
109 Serum dopamine- -hydroxylase in spontaneously hypertensive rats. Experientia 1972 0.75
110 [Insulin resistance]. Nihon Naibunpi Gakkai Zasshi 1987 0.75
111 [Werner's syndrome]. Naika Hokan 1971 0.75
112 Intracellular localization of monoamine oxidase in mammalian salivary glands. J Dent Res 1971 0.75
113 [Receptor abnormalities and diseases. Insulin resistance associated with congenital diseases: insulin receptors in Werner's syndrome, dystrophy and type A extreme insulin resistance]. Nihon Naika Gakkai Zasshi 1987 0.75
114 [Secondary diabetes]. Nihon Rinsho 1989 0.75
115 Assay of trypsin-like protease in rat submandibular saliva and gland. Arch Oral Biol 1986 0.75
116 Monoamine oxidase activities on biogenic amines in the salivary glands of young growing rats. Arch Oral Biol 1980 0.75
117 A lysyl oxidase distinct from amine oxidase in bovine dental pulp. Arch Oral Biol 1976 0.75
118 Insulin receptors on erythrocytes and hepatocytes from streptozotocin induced diabetic rats. Endocrinol Jpn 1982 0.75
119 Analyses of development of insulitogenic T lymphocytes in NOD mice by transplantation of bone marrow, thymus, and pancreas. Transplantation 1990 0.75
120 [Insulin resistance in myotonic dystrophy]. Nihon Rinsho 1991 0.75
121 Effect of starvation of gastric somatostatin release. Life Sci 1981 0.75
122 Antihyperglycemic mechanism of M16209, an antidiabetic agent, in 3T3-L1 adipocytes. Life Sci 1997 0.75
123 Intracellular distribution of endogenous inhibitors of dopamine -hydroxylase in bovine adrenal medulla. Biochem Pharmacol 1972 0.75
124 Developmental changes in the NGF content in the brain of young, growing, low-birth-weight rats. Neurochem Res 1998 0.75
125 Properties of dopamine -hydroxylase in soluble and particulate fractions of bovine adrenal medulla. Biochem Pharmacol 1972 0.75
126 Catecholamine contents and activities of catecholamine synthesizing and inactivating enzymes in the salivary glands of young growing rats. Arch Oral Biol 1980 0.75
127 [Principle and certain problems in radioimmunoassay]. Saishin Igaku 1971 0.75
128 Developmental changes of trypsin-like protease activity in the submandibular glands of male and female young growing rats. Arch Oral Biol 1984 0.75
129 Insulin resistance in a boy with congenital generalized lipodystrophy. Pediatr Res 1988 0.75
130 [Insulin resistance due to genetic defects of insulin receptors]. Nihon Rinsho 1989 0.75
131 A fluorometric study of flavins in human saliva. Arch Oral Biol 1967 0.75
132 [Clinical significance of glucose clamp method in the diagnosis of diabetes mellitus]. Nihon Rinsho 1990 0.75
133 Inhibition of human serum dopamine -hydroxylase after the oral administration of fusaric acid. Experientia 1972 0.75
134 [Lecithin-cholesterol acyltransferase (LCAT) activities in diabetes mellitus]. Horumon To Rinsho 1979 0.75
135 Binding and tyrosine kinase activities of the insulin receptor on Epstein-Barr virus transformed lymphocytes from patients with Werner's syndrome. J Gerontol 1988 0.75
136 [Progress in insulin therapy of NIDDM]. Nihon Naika Gakkai Zasshi 1991 0.75
137 Heterogeneity of non-insulin-dependent diabetes mellitus in HLA types and clinical features: comparison with insulin-dependent diabetes mellitus. Endocrinol Jpn 1991 0.75
138 Possible role of phosphatidylinositol turnover in insulin release from isolated rat pancreatic islets. Horm Metab Res 1984 0.75
139 Effect of leupeptin, a protease inhibitor, on dopa decarboxylase and protease activities in homogenates of submandibular salivary glands from young rats. Arch Oral Biol 1986 0.75
140 [Peroxidase activity of the saliva. 3. Activities of the salivary glands]. Igaku To Seibutsugaku 1967 0.75
141 Catecholamines in the dental pulp. J Dent Res 1971 0.75
142 Islets-activating protein from Bordetella pertussis: enhancement of pancreatic somatostatin release. Horm Metab Res 1983 0.75
143 Purification and properties of human serum dopamine-beta-hydroxylase. Mol Cell Biochem 1977 0.75
144 [Rat serum amylase hydrolyzes starch and glycogen]. Tohoku Shika Daigaku Gakkai Shi 1986 0.75